相似文献
1
Universal access -- but when? Treating the right patient at the right time: access to electrophysiology services in Canada.
Can J Cardiol. 2006 Jul;22(9):741-6. doi: 10.1016/s0828-282x(06)70289-6.
2
General commentary on access to cardiovascular care in Canada: universal access, but when? Treating the right patient at the right time.
Can J Cardiol. 2005 Dec;21(14):1272-6.
3
Universal access: but when? Treating the right patient at the right time: access to cardiac rehabilitation.
Can J Cardiol. 2006 Sep;22(11):905-11. doi: 10.1016/s0828-282x(06)70309-9.
4
Canadian Cardiovascular Society commentary on implantable cardioverter defibrillators in Canada: waiting times and access to care issues.
Can J Cardiol. 2005 May;21 Suppl A:19A-24A.
5
Treating the right patient at the right time: Access to echocardiography in Canada.
Can J Cardiol. 2006 Oct;22(12):1029-33. doi: 10.1016/s0828-282x(06)70318-x.
6
Treating the right patient at the right time: access to care in non-ST segment elevation acute coronary syndromes.
Can J Cardiol. 2005 Nov;21(13):1149-55.
7
Treating the right patient at the right time: access to heart failure care.
Can J Cardiol. 2006 Jul;22(9):749-54. doi: 10.1016/s0828-282x(06)70290-2.
8
Treating the right patient at the right time: Access to cardiac catheterization, percutaneous coronary intervention and cardiac surgery.
Can J Cardiol. 2006 Jun;22(8):679-83. doi: 10.1016/s0828-282x(06)70936-9.
9
Treating the right patient at the right time: access to specialist consultation and non-invasive testing.
Can J Cardiol. 2006 Aug;22(10):819-24. doi: 10.1016/s0828-282x(06)70299-9.
10
A commentary on access to cardiovascular services: nursing roles and initiatives.
Can J Cardiol. 2008 Feb;24(2):107-12. doi: 10.1016/s0828-282x(08)70563-4.
引用本文的文献
1
The Impact of the COVID-19 Pandemic Restrictions on the Provision of Adult Congenital Heart Disease Care Across Canada: A National Survey.
CJC Pediatr Congenit Heart Dis. 2023 Sep 9;2(5):247-252. doi: 10.1016/j.cjcpc.2023.09.002. eCollection 2023 Oct.
2
Access to Cardiovascular Care for Indigenous Peoples in Canada: A Rapid Review.
CJC Open. 2022 Jun 4;4(9):782-791. doi: 10.1016/j.cjco.2022.05.010. eCollection 2022 Sep.
3
How established wait time benchmarks significantly underestimate total wait times for cardiac surgery.
Can J Cardiol. 2010 Jan;26(1):e17-21. doi: 10.1016/s0828-282x(10)70337-8.
4
Treating the right patient at the right time: an innovative approach to the management of atrial fibrillation.
Can J Cardiol. 2008 Mar;24(3):195-8. doi: 10.1016/s0828-282x(08)70583-x.
5
Treating the right patient at the right time: Access to echocardiography in Canada.
Can J Cardiol. 2006 Oct;22(12):1029-33. doi: 10.1016/s0828-282x(06)70318-x.
本文引用的文献
1
Canadian Cardiovascular Society consensus conference recommendations on heart failure 2006: diagnosis and management.
Can J Cardiol. 2006 Jan;22(1):23-45. doi: 10.1016/s0828-282x(06)70237-9.
2
Why should we care about CARE-HF?
J Am Coll Cardiol. 2005 Dec 20;46(12):2199-203. doi: 10.1016/j.jacc.2005.07.057.
3
Catheter ablation treatment in patients with drug-refractory atrial fibrillation: a prospective, multi-centre, randomized, controlled study (Catheter Ablation For The Cure Of Atrial Fibrillation Study).
Eur Heart J. 2006 Jan;27(2):216-21. doi: 10.1093/eurheartj/ehi583. Epub 2005 Oct 7.
4
The Task Force for the diagnosis and treatment of chronic heart failure of the European Society of Cardiology. Guidelines for the diagnosis and treatment of chronic heart failure: full text (update 2005).
Eur Heart J. 2005 Nov;26(22):2472; author reply 2473-4. doi: 10.1093/eurheartj/ehi549. Epub 2005 Oct 4.
5
Implantable cardioverter defibrillators and cardiac resynchronization therapy in patients with left ventricular dysfunction: randomized trial evidence through 2004.
Am Heart J. 2005 Jun;149(6):1020-34. doi: 10.1016/j.ahj.2005.02.005.
6
Canadian Cardiovascular Society commentary on implantable cardioverter defibrillators in Canada: waiting times and access to care issues.
Can J Cardiol. 2005 May;21 Suppl A:19A-24A.
7
Canadian Cardiovascular Society/Canadian Heart Rhythm Society position paper on implantable cardioverter defibrillator use in Canada.
Can J Cardiol. 2005 May;21 Suppl A:11A-18A.
8
Downward delegation of implantable cardioverter defibrillator decision-making in a restricted-resource environment: the pitfalls of bedside rationing.
Can J Cardiol. 2005 May 15;21(7):595-9.
9
The effect of cardiac resynchronization on morbidity and mortality in heart failure.
N Engl J Med. 2005 Apr 14;352(15):1539-49. doi: 10.1056/NEJMoa050496. Epub 2005 Mar 7.
10
Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure.
N Engl J Med. 2004 May 20;350(21):2140-50. doi: 10.1056/NEJMoa032423.
Zotero 插件